Phong Phu Pharmaceutical JSC (HNX: PPP)
Vietnam
· Delayed Price · Currency is VND
16,600
-100 (-0.60%)
At close: Jan 24, 2025
HNX:PPP Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Net Income | 17,359 | 20,120 | 20,611 | 16,893 | 9,815 | Upgrade
|
Depreciation & Amortization | 4,213 | 4,816 | 6,225 | 6,178 | 6,196 | Upgrade
|
Loss (Gain) From Sale of Assets | -1,412 | -1,328 | -581.01 | -109.53 | -187.8 | Upgrade
|
Other Operating Activities | -1,486 | -68.32 | 385.46 | 252.37 | -2,852 | Upgrade
|
Change in Accounts Receivable | 1,161 | 597.01 | -4,178 | -110.06 | 1,525 | Upgrade
|
Change in Inventory | -4,626 | 4,838 | 4,842 | -7,656 | 2,862 | Upgrade
|
Change in Accounts Payable | 1,297 | -8,201 | -6,416 | 4,027 | -6,912 | Upgrade
|
Change in Other Net Operating Assets | 831.64 | -781.34 | 48.3 | -196.47 | -252.3 | Upgrade
|
Operating Cash Flow | 17,336 | 19,992 | 20,936 | 19,279 | 10,194 | Upgrade
|
Operating Cash Flow Growth | -13.29% | -4.51% | 8.60% | 89.12% | -58.90% | Upgrade
|
Capital Expenditures | -549.86 | -2,564 | -818.79 | -1,149 | -1,149 | Upgrade
|
Sale of Property, Plant & Equipment | 22.35 | 0.94 | - | - | 1.47 | Upgrade
|
Other Investing Activities | 1,573 | 782.43 | 387.81 | 56.05 | 223.1 | Upgrade
|
Investing Cash Flow | -6,499 | -9,344 | -10,431 | -1,093 | 3,575 | Upgrade
|
Short-Term Debt Issued | - | - | - | 9,249 | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 3,132 | Upgrade
|
Total Debt Issued | - | - | - | 9,249 | 3,132 | Upgrade
|
Short-Term Debt Repaid | - | - | -2,000 | -18,351 | - | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | -10,065 | Upgrade
|
Total Debt Repaid | - | - | -2,000 | -18,351 | -10,065 | Upgrade
|
Net Debt Issued (Repaid) | - | - | -2,000 | -9,102 | -6,933 | Upgrade
|
Common Dividends Paid | -10,442 | -12,468 | -10,323 | -5,975 | -7,324 | Upgrade
|
Financing Cash Flow | -10,442 | -12,468 | -12,323 | -15,077 | -14,257 | Upgrade
|
Net Cash Flow | 394.59 | -1,819 | -1,817 | 3,109 | -487.6 | Upgrade
|
Free Cash Flow | 16,787 | 17,428 | 20,117 | 18,129 | 9,045 | Upgrade
|
Free Cash Flow Growth | -3.68% | -13.37% | 10.97% | 100.44% | -61.94% | Upgrade
|
Free Cash Flow Margin | 12.20% | 11.45% | 13.36% | 13.60% | 7.78% | Upgrade
|
Free Cash Flow Per Share | 1707.78 | 1786.98 | 2061.38 | 1851.27 | 916.90 | Upgrade
|
Cash Interest Paid | - | - | 45.36 | 446.78 | 1,663 | Upgrade
|
Cash Income Tax Paid | 4,456 | 4,116 | 4,420 | 2,632 | 2,691 | Upgrade
|
Levered Free Cash Flow | 14,816 | 17,338 | 17,742 | 21,833 | 7,712 | Upgrade
|
Unlevered Free Cash Flow | 14,816 | 17,338 | 17,770 | 22,105 | 8,742 | Upgrade
|
Change in Net Working Capital | 1,486 | -628.56 | 3,382 | -4,768 | 4,230 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.